Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Pyrovalerone (Centroton, 4-Methyl-β-keto-prolintane, Thymergix, O-2371) is a central nervous system (CNS) stimulant that acts as a norepinephrine–dopamine reuptake inhibitor (NDRI). It was developed in the 1980s and had briefly been approved in Spain and France for chronic fatigue or lethargy and as an appetite suppressant, but was withdrawn from both…
Overview, Related Topics & Entities
Explore the main themes, entities and connections around Pyrovalerone. Start with the topic map, then use the sections below for research and deeper semantic analysis.
Start with a few of the strongest sections from the source topic. These are research directions, not a list of keywords you must use.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the full topic structure. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
See the strongest relationship patterns around the current topic before diving into the raw triples.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
abuse appetite prolintane number mdpv stimulant acts developed lethargy dependence structural α-pvp anxiety sleep insomnia trembling shaking withdrawal depression centroton
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Pyrovalerone | 3D model (JSmol) | Interactive image | 1.00 | infobox |
| Pyrovalerone | ATC code | none | 1.00 | infobox |
| Pyrovalerone | CAS Number | 3563-49-3 N 1147-62-2 (hydrochloride) | 1.00 | infobox |
| Pyrovalerone | ChEMBL | ChEMBL201960 Y | 1.00 | infobox |
| Pyrovalerone | ChemSpider | 13733 Y | 1.00 | infobox |
| Pyrovalerone | Chirality | Racemic mixture | 1.00 | infobox |
| Pyrovalerone | CompTox Dashboard (EPA) | DTXSID20863194 | 1.00 | infobox |
| Pyrovalerone | ECHA InfoCard | 100.230.426 | 1.00 | infobox |
| Pyrovalerone | Formula | C16H23NO | 1.00 | infobox |
| Pyrovalerone | KEGG | D05663 Y | 1.00 | infobox |
| Pyrovalerone | Legal status | AU: S4 (Prescription only) | 1.00 | infobox |
| Pyrovalerone | Legal status | BR: Class B1 (Psychoactive drugs) | 1.00 | infobox |
| Pyrovalerone | Legal status | CA: Schedule IV | 1.00 | infobox |
| Pyrovalerone | Legal status | DE: Anlage II (Authorized trade only, not prescriptible) | 1.00 | infobox |
| Pyrovalerone | Legal status | UK: Class C | 1.00 | infobox |
| Pyrovalerone | Legal status | US: Schedule V | 1.00 | infobox |
| Pyrovalerone | Molar mass | 245.366 g·mol−1 | 1.00 | infobox |
| Pyrovalerone | PubChem CID | 14373 | 1.00 | infobox |
| Pyrovalerone | Routes of administration | By mouth | 1.00 | infobox |
| Pyrovalerone | UNII | VOU69C02JP | 1.00 | infobox |
These clusters group vocabulary that occurs around closely connected concepts in the source material.
Bridges can reveal useful research angles that are easy to miss in a flat list of related terms.